Showing results (21-30 of 93) with videos related to
Sort By:
Pageof 10
Clinical Pharmacokinetics|January 1, 1984
Tinidazole pharmacokinetics in severe renal failureR A Robson, R R Bailey, J R SharmanProceedings of the Royal Society of Medicine|January 1, 1976
The evaluation of lipoprotein changes during gemfibrozil treatmentE D Janus, D Costa, I C Ononogbu, et al.Australian and New Zealand Journal of Medicine|June 1, 1994
Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysemaL Cook, E D Janus, S Brenton, et al.Chinese Medical Journal|June 1, 1997
Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populationsR W Pang, B Chen, E D Janus, et al.Journal of Epidemiology and Community Health|September 1, 1986
Trends in blood lead levels in Christchurch (NZ) and environs 1978-85D Hinton, P A Coope, W A Malpress, et al.Atherosclerosis|November 1, 1985
Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatmentE D Janus, S Grant, C J Lintott, et al.Biochemical Medicine and Metabolic Biology|June 1, 1988
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentrationW H Sutherland, E D Janus, E R Nye, et al.The New Zealand Medical Journal|November 14, 1984
Industrial lead exposure: a review of blood lead levels in South Island industries, 1974-83D Hinton, B C Cresswell, E D Janus, et al.Australian and New Zealand Journal of Medicine|December 1, 1995
Alpha-1-antitrypsin PLowell: a normally functioning variant present in low concentrationL Cook, J Burdon, S Brenton, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 10, 2002
Central obesity predicts the worsening of glycemia in southern ChineseN M Wat, T H Lam, E D Janus, et al.Pageof 10